Cargando…
Relationship between Azathioprine metabolites and therapeutic efficacy in Chinese patients with neuromyelitis optica spectrum disorders
BACKGROUND: Neuromyelitis optica spectrum disorders (NMOSD) are demyelinating autoimmune diseases in the central nervous system (CNS) that are characterized by a high relapse rate and the presence of anti-aquaporin 4 antibodies (AQP4-IgG) in the serum. Azathioprine (AZA) is a first-line immunomodula...
Autores principales: | Li, Xindi, Mei, Shenghui, Gong, Xiaoqing, Zhou, Heng, Yang, Li, Zhou, Anna, Liu, Yonghong, Li, Xingang, Zhao, Zhigang, Zhang, Xinghu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498874/ https://www.ncbi.nlm.nih.gov/pubmed/28679367 http://dx.doi.org/10.1186/s12883-017-0903-5 |
Ejemplares similares
-
Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
por: Yang, Yang, et al.
Publicado: (2021) -
CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders
por: Wei, Yuzhen, et al.
Publicado: (2018) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Cortical Thinning and Ventricle Enlargement in Neuromyelitis Optica Spectrum Disorders
por: Tian, De-Cai, et al.
Publicado: (2020) -
Mortality of neuromyelitis optica spectrum disorders in a Chinese population
por: Du, Qin, et al.
Publicado: (2021)